2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab
NCT00600340
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
564
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Breast Cancer
Interventions
BIOLOGICAL:
Bevacizumab and Paclitaxel
BIOLOGICAL:
Bevacizumab and Capecitabine
Sponsor
Central European Cooperative Oncology Group